VEGFA and neoplasm: Referring to the combination of gene copy number variation of VEGFA and its overexpression in the tumor, it was noteworthy that in the Control Disease group, the two variables are combined in 37.5% of cases compared with 7.14% observed in the Rapid Progression group.